0.80%| Prev Close: | 1.15 |
|---|---|
| Open: | 1.15 |
| Bid: | 1.10 x 600 |
| Ask: | 1.17 x 100 |
| 1y Target Est: | N/A |
| Beta: | 2.01 |
| Next Earnings Date: | N/A |
| Day's Range: | 1.14 - 1.18 |
|---|---|
| 52wk Range: | 1.01 - 3.66 |
| Volume: | 135,599 |
| Avg Vol (3m): | 198,854 |
| Market Cap: | 102.18M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.86 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial ResultsBusiness Wire(Fri, May 10)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Fri, May 10)
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed MergerBusiness Wire(Wed, May 8)
- Huge Potential But Tough Entry For Female Sexual Dysfunction Drugsat Seeking Alpha(Tue, May 7)
- 4 Bio Stocks to Buy Todayat Motley Fool(Wed, May 1)
- Ceregene Reports Data From Parkinson's Disease Phase 2b StudyPR Newswire(Fri, Apr 19)
- BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger AgreementBusiness Wire(Fri, Apr 12)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MateriaEDGAR Online(Fri, Apr 12)
- Reviving The Blockbuster Potential Of Libigel For Biosante And Antares Pharmaat Seeking Alpha(Mon, Apr 8)
- Antares: A Compelling Long Term Investmentat Seeking Alpha(Thu, Mar 21)
- BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders to Vote “FOR” Proposed Merger with ANI Pharmaceuticals, Inc.Business Wire(Tue, Mar 19)
- BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters toEDGAR Online(Fri, Mar 15)
- BioSante Pharmaceuticals Announces Adjournment of Its Stockholders Meeting Until April 12, 2013Business Wire(Fri, Mar 15)
- Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 TrialPR Newswire(Wed, Mar 13)
- Biotech Industry Looks to Benefit From FDA's New "Breakthrough" DesignationMarketwired(Tue, Mar 12)
Press Releases
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial ResultsBusiness Wire(Fri, May 10)
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed MergerBusiness Wire(Wed, May 8)
- Ceregene Reports Data From Parkinson's Disease Phase 2b StudyPR Newswire(Fri, Apr 19)
Reports
- BIOSANTE PHARMACEUTICALS INC (BPAX) 12-months forecastPechala's Reports(May 18)
- BPAX: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 17)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(May 17)